Table of Contents

Articles

• You have access

  Phosphorodiamidate Morpholino Antisense Oligomers Inhibit Expression of Human Cytochrome P450 3A4 and Alter Selected Drug Metabolism

  Vikram Arora, Melissa L. Cate, Chandramallika Ghosh and Patrick L. Iversen

  Drug Metabolism and Disposition July 2002, 30 (7) 757-762; DOI: https://doi.org/10.1124/dmd.30.7.757
• You have access

  Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1

  Feng R. Luo, Pankaj V. Paranjpe, Ailan Guo, Eric Rubin and Patrick Sinko

  Drug Metabolism and Disposition July 2002, 30 (7) 763-770; DOI: https://doi.org/10.1124/dmd.30.7.763
• You have access

  The Pharmacokinetics of a Thiazole Benzenesulfonamide β₃-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability

  Ralph A. Stearns, Randy R. Miller, Wei Tang, Gloria Y. Kwei, Frank S. Tang, Robert J. Mathvink, Elizabeth M. Naylor, Dawn Chitty, Vincent J. Colandrea, Ann E. Weber, Adria E. Colletti, John R. Strauss, Carol Ann Keohane, William P. Feeney, Susan A. Iliff and Shuet-Hing Lee Chiu

  Drug Metabolism and Disposition July 2002, 30 (7) 771-777; DOI: https://doi.org/10.1124/dmd.30.7.771
• You have access

  Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β₃-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate

  Wei Tang, Ralph A. Stearns, Randall R. Miller, Jason S. Ngui, Robert J. Mathvink, Ann E. Weber, Gloria Y. Kwei, John R. Strauss, Carol A. Keohane, George A. Doss, Shuet-Hing L. Chiu and Thomas A. Baillie

  Drug Metabolism and Disposition July 2002, 30 (7) 778-787; DOI: https://doi.org/10.1124/dmd.30.7.778
• You have access

  Identification of Human Hepatic Cytochrome P450 Sources of N-alkylprotoporphyrin IX after Interaction with Porphyrinogenic Xenobiotics, Implications for Detection of Xenobiotic-Induced Porphyria in Humans

  James A. Lavigne, Kanji Nakatsu and Gerald S. Marks

  Drug Metabolism and Disposition July 2002, 30 (7) 788-794; DOI: https://doi.org/10.1124/dmd.30.7.788
• You have access

  CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes

  Gang Luo, Mark Cunningham, Sean Kim, Tim Burn, Jianrong Lin, Michael Sinz, Geraldine Hamilton, Christopher Rizzo, Summer Jolley, Darryl Gilbert, April Downey, Daniel Mudra, Richard Graham, Kathy Carroll, Jindong Xie, Ajay Madan, Andrew Parkinson, Dave Christ, Bernard Selling, Edward LeCluyse and Liang-Shang Gan

  Drug Metabolism and Disposition July 2002, 30 (7) 795-804; DOI: https://doi.org/10.1124/dmd.30.7.795
• You have access

  In Vitro Interactions between a Potential Muscle Relaxant E2101 and Human Cytochromes P450

  Zhi-Yi Zhang, Belinda M. King, Nevena N. Mollova and Y. Nancy Wong

  Drug Metabolism and Disposition July 2002, 30 (7) 805-813; DOI: https://doi.org/10.1124/dmd.30.7.805
• You have access

  The Effect of Cyclophosphamide with and without Dexamethasone on Cytochrome P450 3A4 and 2B6 in Human Hepatocytes

  Celeste Lindley, Geraldine Hamilton, Jeannine S. McCune, Stephanie Faucette, Stacy S. Shord, Roy L. Hawke, Hongbing Wang, Darryl Gilbert, Summer Jolley, Bingfang Yan and Edward L. LeCluyse

  Drug Metabolism and Disposition July 2002, 30 (7) 814-822; DOI: https://doi.org/10.1124/dmd.30.7.814
• You have access

  Evaluation of Accelerator Mass Spectrometry in a Human Mass Balance and Pharmacokinetic Study–Experience with¹⁴C-labeled (R)-6-[Amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a Farnesyl Transferase Inhibitor

  R. C. Garner, I. Goris, A. A. E. Laenen, E. Vanhoutte, W. Meuldermans, S. Gregory, J. V. Garner, D. Leong, M. Whattam, A. Calam and C. A. W. Snel

  Drug Metabolism and Disposition July 2002, 30 (7) 823-830; DOI: https://doi.org/10.1124/dmd.30.7.823
• You have access

  Measurement of Michaelis Constants for Cytochrome P450-Mediated Biotransformation Reactions Using a Substrate Depletion Approach

  R. Scott Obach and Anne E. Reed-Hagen

  Drug Metabolism and Disposition July 2002, 30 (7) 831-837; DOI: https://doi.org/10.1124/dmd.30.7.831
• You have access

  Tissue Distribution and Chemical Induction of Multiple Drug Resistance Genes in Rats

  James M. Brady, Nathan J. Cherrington, Dylan P. Hartley, Susan C. Buist, Ning Li and Curtis D. Klaassen

  Drug Metabolism and Disposition July 2002, 30 (7) 838-844; DOI: https://doi.org/10.1124/dmd.30.7.838
• You have access

  Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.

  David M. Stresser, Stephanie D. Turner, Andrew P. Blanchard, Vaughn P. Miller and Charles L. Crespi

  Drug Metabolism and Disposition July 2002, 30 (7) 845-852; DOI: https://doi.org/10.1124/dmd.30.7.845
• You have access

  Contribution of CYP3A4, CYP2B6, and CYP2C9 Isoforms toN-Demethylation of Ketamine in Human Liver Microsomes

  Youssef Hijazi and Roselyne Boulieu

  Drug Metabolism and Disposition July 2002, 30 (7) 853-858; DOI: https://doi.org/10.1124/dmd.30.7.853